Revenue

As we embark on a new trading month, JPMorgan has updated its Analyst Focus list with some potential outperformers in the market. In the wake of a shaky start to the month, with significant drops in major indices, investors are seeking guidance on where to put their money next. JPMorgan’s focus list includes stocks that
0 Comments
Moderna recently reported its second-quarter revenue, which surpassed expectations, but the biotech company decided to slash its full-year sales guidance. The decreased guidance was attributed to lower anticipated sales in Europe, a competitive market for respiratory vaccines in the U.S., and the potential for deferred international revenue until 2025. Despite this, Moderna is now projecting
0 Comments
After Microsoft’s post-earnings report, the stock experienced a 1% dip due to disappointing cloud revenue despite strong overall results in the fiscal fourth quarter. The Intelligent Cloud segment brought in $28.52 billion in revenue, slightly lower than the $28.68 billion expected by analysts. However, Wall Street analysts believe that this pullback presents a buying opportunity
0 Comments
The increase in municipal bond issuance during July has been attributed to several factors such as front-loaded issuance ahead of the election, a lower rate environment, and a breakneck pace of supply. These trends have continued for the seventh consecutive month, with volume rising to $33.935 billion in 576 issues, representing a 21.2% increase from
0 Comments
Spirit Airlines, known for its budget-friendly approach to air travel, is making significant changes to its ticketing options in an effort to attract more customers and increase revenue. Starting next month, the Florida-based carrier will introduce four categories of service aimed at providing travelers with more choices and added perks. From “Go Big” Tickets offering
0 Comments
California’s fiscal 2025 budget has been a subject of concern due to the revenue gap that emerged in fiscal 2024. Fitch Ratings has pointed out that while some adjustments have been made to close the gap, further actions will be necessary to achieve fiscal balance in the coming years. The state’s issuer default rating stands
0 Comments
Bristol Myers Squibb recently announced its second-quarter earnings, which exceeded expectations, indicating a positive financial performance for the pharmaceutical giant. The company reported revenue and earnings that surpassed forecasts, prompting an increase in its full-year guidance. This successful quarter comes as Bristol Myers implements cost-cutting measures to streamline operations and invest in key drug brands
0 Comments